95 related articles for article (PubMed ID: 1997006)
1. Cellular toxicity of sulfamethoxazole reactive metabolites--II. Inhibition of natural killer activity in human peripheral blood mononuclear cells.
Leeder JS; Nakhooda A; Spielberg SP; Dosch HM
Biochem Pharmacol; 1991 Feb; 41(4):575-83. PubMed ID: 1997006
[TBL] [Abstract][Full Text] [Related]
2. Cellular toxicity of sulfamethoxazole reactive metabolites--I. Inhibition of intracellular esterase activity prior to cell death.
Leeder JS; Dosch HM; Spielberg SP
Biochem Pharmacol; 1991 Feb; 41(4):567-74. PubMed ID: 1997005
[TBL] [Abstract][Full Text] [Related]
3. Reactions of the nitroso and hydroxylamine metabolites of sulfamethoxazole with reduced glutathione. Implications for idiosyncratic toxicity.
Cribb AE; Miller M; Leeder JS; Hill J; Spielberg SP
Drug Metab Dispos; 1991; 19(5):900-6. PubMed ID: 1686233
[TBL] [Abstract][Full Text] [Related]
4. Influence of reduced glutathione on the proliferative response of sulfamethoxazole-specific and sulfamethoxazole-metabolite-specific human CD4+ T-cells.
Burkhart C; von Greyerz S; Depta JP; Naisbitt DJ; Britschgi M; Park KB; Pichler WJ
Br J Pharmacol; 2001 Feb; 132(3):623-30. PubMed ID: 11159714
[TBL] [Abstract][Full Text] [Related]
5. In vitro formation, disposition and toxicity of N-acetoxy-sulfamethoxazole, a potential mediator of sulfamethoxazole toxicity.
Nakamura H; Uetrecht J; Cribb AE; Miller MA; Zahid N; Hill J; Josephy PD; Grant DM; Spielberg SP
J Pharmacol Exp Ther; 1995 Sep; 274(3):1099-104. PubMed ID: 7562475
[TBL] [Abstract][Full Text] [Related]
6. In vitro cytotoxicity as a marker of hypersensitivity to sulphamethoxazole in patients with HIV.
Carr A; Tindall B; Penny R; Cooper DA
Clin Exp Immunol; 1993 Oct; 94(1):21-5. PubMed ID: 8403509
[TBL] [Abstract][Full Text] [Related]
7. Roles of endogenous ascorbate and glutathione in the cellular reduction and cytotoxicity of sulfamethoxazole-nitroso.
Lavergne SN; Kurian JR; Bajad SU; Maki JE; Yoder AR; Guzinski MV; Graziano FM; Trepanier LA
Toxicology; 2006 May; 222(1-2):25-36. PubMed ID: 16473451
[TBL] [Abstract][Full Text] [Related]
8. Cytotoxicity of sulfonamide reactive metabolites: apoptosis and selective toxicity of CD8(+) cells by the hydroxylamine of sulfamethoxazole.
Hess DA; Sisson ME; Suria H; Wijsman J; Puvanesasingham R; Madrenas J; Rieder MJ
FASEB J; 1999 Oct; 13(13):1688-98. PubMed ID: 10506572
[TBL] [Abstract][Full Text] [Related]
9. Modulation of human natural killer cell function by L-leucine methyl ester: monocyte-dependent depletion from human peripheral blood mononuclear cells.
Thiele DL; Lipsky PE
J Immunol; 1985 Feb; 134(2):786-93. PubMed ID: 3965574
[TBL] [Abstract][Full Text] [Related]
10. Combined ascorbate and glutathione deficiency leads to decreased cytochrome b5 expression and impaired reduction of sulfamethoxazole hydroxylamine.
Bhusari S; Abouraya M; Padilla ML; Pinkerton ME; Drescher NJ; Sacco JC; Trepanier LA
Arch Toxicol; 2010 Aug; 84(8):597-607. PubMed ID: 20221587
[TBL] [Abstract][Full Text] [Related]
11. Covalent binding of sulfamethoxazole reactive metabolites to human and rat liver subcellular fractions assessed by immunochemical detection.
Cribb AE; Nuss CE; Alberts DW; Lamphere DB; Grant DM; Grossman SJ; Spielberg SP
Chem Res Toxicol; 1996 Mar; 9(2):500-7. PubMed ID: 8839055
[TBL] [Abstract][Full Text] [Related]
12. Role of Oxidative Stress in Hypersensitivity Reactions to Sulfonamides.
Elzagallaai AA; Sultan EA; Bend JR; Abuzgaia AM; Loubani E; Rieder MJ
J Clin Pharmacol; 2020 Mar; 60(3):409-421. PubMed ID: 31709574
[TBL] [Abstract][Full Text] [Related]
13. Fluorescence-based viability assay for studies of reactive drug intermediates.
Leeder JS; Dosch HM; Harper PA; Lam P; Spielberg SP
Anal Biochem; 1989 Mar; 177(2):364-72. PubMed ID: 2729556
[TBL] [Abstract][Full Text] [Related]
14. The hydroxylamine of sulfamethoxazole synergizes with FK506 and cyclosporin A, inhibiting T-cell proliferation.
Hess DA; Bird IA; Almawi WY; Rieder MJ
J Pharmacol Exp Ther; 1997 Apr; 281(1):540-8. PubMed ID: 9103542
[TBL] [Abstract][Full Text] [Related]
15. Modulation of human natural killer cytotoxicity by influenza virus and its subunit protein.
Ali SA; Rees RC; Oxford J
Immunology; 1984 Aug; 52(4):687-95. PubMed ID: 6746000
[TBL] [Abstract][Full Text] [Related]
16. Novel non-labile covalent binding of sulfamethoxazole reactive metabolites to cultured human lymphoid cells.
Summan M; Cribb AE
Chem Biol Interact; 2002 Nov; 142(1-2):155-73. PubMed ID: 12399161
[TBL] [Abstract][Full Text] [Related]
17. Natural killer and lymphokine-activated killer cell activities from human marrow precursors. II. The effects of IL-3 and IL-4.
Keever CA; Pekle K; Gazzola MV; Collins NH; Bourhis JH; Gillio A
J Immunol; 1989 Nov; 143(10):3241-9. PubMed ID: 2809200
[TBL] [Abstract][Full Text] [Related]
18. Evidence for an early calcium-independent event in the activation of the human natural killer cell cytolytic mechanism.
Brahmi Z; Bray RA; Abrams SI
J Immunol; 1985 Dec; 135(6):4108-13. PubMed ID: 3864859
[TBL] [Abstract][Full Text] [Related]
19. Effects of maximal exercise on natural killer (NK) cell cytotoxicity and responsiveness to interferon-alpha in the young and old.
Woods JA; Evans JK; Wolters BW; Ceddia MA; McAuley E
J Gerontol A Biol Sci Med Sci; 1998 Nov; 53(6):B430-7. PubMed ID: 9823739
[TBL] [Abstract][Full Text] [Related]
20. An in vitro investigation of predisposition to sulphonamide idiosyncratic toxicity in dogs.
Cribb AE; Spielberg SP
Vet Res Commun; 1990; 14(3):241-52. PubMed ID: 2382408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]